The appointment of Lynne Patton, who planned Eric Trump’s wedding, to head the Department of Housing and Urban Development’s New York office, is raising eyebrows.
colgate close housing development fund corp.
115 west 31st street
new york, new york, 10001
NYS Entity Status
NYS Filing Date
JULY 09, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2013 - COLGATE CLOSE HOUSING DEVELOPMENT FUND CORP.
AROUND THE WEB
- Trump Family Wedding Planner to Head New York’s Federal Housing Office
By YAMICHE ALCINDOR and J. DAVID GOODMAN - Friday Jun 16, 2017
- ‘I’d Be Hurt and Upset’: Cities Fear Trump’s Cuts to Urban Programs
By YAMICHE ALCINDOR - Friday Mar 17, 2017
President Trump’s proposed cuts to the Department of Housing and Urban Development would eliminate programs cities have used to fund things like Meals on Wheels.
- Greater Minnesota Housing Fund Launches Impact Investment Fund
By email@example.com (Matt Sinclair) - Thursday Jun 8, 2017
A public-private partnership, the new fund will support efforts to acquire and preserve affordable housing in the Twin Cities....
- De Blasio’s Plan to Create 100,000 Jobs: Find 40,000, and Keep Eyes Open
By WILLIAM NEUMAN and J. DAVID GOODMAN - Thursday Jun 15, 2017
Mayor Bill de Blasio announced initiatives toward his goal of creating 100,000 jobs in New York City, but couldn’t say where 60,000 of those would come from.
- Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
By Frank Vinluan - Wednesday Jun 14, 2017
The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]
- Five Sites of New York’s L.G.B.T. History
Monday Jun 19, 2017
Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
- Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
By Frank Vinluan - Tuesday May 30, 2017
Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]